Viropro Pharma Inc. Appoints Director Of Business Development For Latin-America


MONTREAL, Feb. 22, 2005 (PRIMEZONE) -- Viropro Pharma Inc., a subsidiary of Viropro Inc. (OTCBB:VPRO), today announced the appointment of Mr. Rinaldo Mancin to the position of Director, Business Development for Latin-America, based in Brasilia, Brazil. Effective immediately, Mr. Mancin will oversee all corporate activities related to the development of products and technologies in Latin America.

Mr. Mancin brings to Viropro Pharma over 15 years experience in the management and implementation of large-scale projects in Brazil, most of which were financed by G7 countries, the World Bank and the European Union.

Mr. Mancin is a former Executive Secretary for the National Genetic Resources Council in Brazil, where he played a key role in development and implementation of policies in the biotechnological sector.

Mr. Mancin has also acted as Chief Negotiator for environmental and biotechnological projects on behalf of the Brazilian government with a number of prestigious international agencies, such as the Convention on Biological Diversity (CBD), the World Intellectual Property Organization (WIPO), and the World Trade Organization (WTO). Mr. Mancin obtained a master's degree in Sustainable Development from the University of Brasilia (UnB).

With his impressive portfolio of private and institutional contacts, Mr. Mancin will bring to Viropro Pharma critical expertise in the implementation of strategies aimed at successful penetration of the Brazilian market, as well as in the corporate finance.

"We are very proud to welcome to Viropro Pharma a person of Mr. Mancin's expertise and in-depth knowledge of the biotechnology sector, as it has become essential for our company's portfolio to ensure a constant flow of promising candidates," declared Halina Brafman-LaBrie, vice-president in charge of business development and marketing. "It was imperative for Viropro Pharma to have a permanent presence in Brazil in order to develop and sustain growth of our business in the area of biopharmaceuticals, diagnostics and consumer products. Brazilian market, the largest in South America, represents a significant growth and revenue potential, in addition to being a highly-favored gateway into all Latin-American countries," she added.

About Viropro Inc.

Viropro, Inc. (OTCBB:VPRO) is establishing a growth portfolio in Life Sciences markets through strategic alliances and revenue-producing acquisitions with the potential for continued shareholder value.

Viropro, Inc.'s Safe Harbor Statement

Except for any historic information contained herein, the matters discussed in this press release contain forward-looking statements that involve risks and uncertainties, which are subject to section 27A of the Securities Act of 1933 and section 21E of the Exchange Act of 1934, and are subject to safe harbor created by these sections. Any statements that express or involve discussions with respect to predictions, beliefs, plans, projections, objectives, goals, assumptions of future events or performances are not statements of historical fact and may be "forward looking statements". Forward looking statements in this release may be identified through the use of such words as "expects", "anticipates", "estimates", "believes", or statements indicating certain actions "may", "could", or "might" occur. Actual results, performance or achievements could differ materially from those anticipated in such forward-looking statements, which involve numerous risks and uncertainties, including the Company's ability to market its products and services in a competitive environment as well as other factors.

The Firm Of Trivor FC Manages All Of CNC Inc. And Viropro Pharma's Financial Communications. Direct All Inquiries To:



 Nick Mylonakis
 (514) 731-5552, Ext. 297
 TUnmylonakis@trivorgroup.comUT

 Georges Amar
 (514) 731-5552, Ext. 237
 TUgamar@trivorgroup.comUT

 Jeff Morrisson
 (514) 731-5552 Extension 225
 TUjmorrisson@trivorgroup.comUT

 Helene Dupont
 (514) 731-5552 Extension 285
 TUjmorrisson@trivorgroup.comUT